Top 5 Telehealth Platform Solutions in 2026
Our order is Doximity (9.2/10), Teladoc Health (8.7/10), Amwell (8.2/10), Doxy.me (7.8/10), then eVisit (7.4/10). Doximity wins when clinicians already rely on its dialer and video stack daily. Teladoc Health covers the widest employer and payer footprint. Amwell fits hybrid hospital programs. Doxy.me favors rapid outpatient launches. eVisit targets enterprises branding virtual visits around local clinicians.
How we ranked
Between January 2025 and May 2026 we read clinician threads on Reddit, payer debates such as this telehealth carve-out discussion, hospitalist setup notes on r/hospitalist, therapist reactions to Doxy.me updates, and trainee commentary referencing Doximity rankings. Third-party grids came from TrustRadius, filings and tape via CNBC, regulatory context from WIRED, workflow interviews on Medium, expansion reporting from TechCrunch, health-system messaging on Facebook, and official updates on X.
- Privacy, security, and compliance clarity (0.30) — HIPAA-ready documentation for video, routing, and chart closure beats glossy roadmaps when auditors arrive.
- Pricing and overall value (0.20) — We modeled list pricing, bundled payer economics, and per-visit tradeoffs facing thin margins.
- Clinical workflow and usability (0.20) — Scheduling friction or clumsy visit closure kills adoption faster than missing logos.
- Integration breadth with records and scheduling (0.20) — Electronic health record hooks and operational tooling decide whether programs graduate beyond pilots.
- Community sentiment (Reddit, reviews, social) (0.10) — Narratives break ties once quantitative scores converge.
The Top 5
#1Doximity9.2/10
Verdict: Best when your physicians already live inside Doximity and want televideo aligned with dialer muscle memory.
Pros
- Membership claims covering more than four in five U.S. physicians accelerate rollout because credentialing teams encounter familiar software.
- KLAS highlights summarized on Doximity’s press wire reassure IT buyers comparing inpatient and ambulatory stacks.
- CNBC trading-week reporting documented renewed momentum after fiscal results beat expectations heading into 2025.
Cons
- Rankings and survey baggage tied to the broader brand still surfaces in forums such as r/premed, unrelated to televideo yet requiring executive messaging prep.
- Groups without incumbent adoption still owe training budget before parity with simpler SMB tools.
Best for: U.S. medical groups standardizing outpatient telemedicine where clinicians already collaborate through the network.
Evidence: KLAS-oriented announcements on Doximity’s press site align with how vendor teams defend procurement scorecards, while CNBC coverage ties revenue durability to continued workflow investment including AI-assisted documentation adjacent to visits.
Links
- Official site: doximity.com
- Workplace solutions: solutions overview
- Reddit: rankings skepticism thread referencing Doximity
- TrustRadius: Doximity Talent Finder profile
#2Teladoc Health8.7/10
Verdict: The incumbent national brand when employers or payers demand one umbrella for navigation, primary care, and behavioral access.
Pros
- GlobeNewswire earnings summaries still describe multi-billion-dollar revenue scale valuable during enterprise sourcing.
- Deals such as Catapult Health extend diagnostics closer to longitudinal virtual care.
- Public scrutiny from outlets including CNBC keeps finance and clinical stakeholders aligned on roadmap reality.
Cons
- GAAP losses remain visible inside the same GlobeNewswire filings recap, forcing disciplined governance reviews.
- Benefit booklet quirks still confuse members, per Reddit threads contrasting telehealth carve-outs.
Best for: National employers, health plans, and multispecialty groups needing unified contracting across geographies.
Evidence: GlobeNewswire financial summaries anchor Teladoc Health as measurable incumbent infrastructure, while CNBC earnings reporting clarifies how investors react between integrated-care upside and persistent restructuring noise.
Links
- Official site: teladochealth.com
- Organizations hub: enterprise overview
- Reddit: member confusion about bundled Teladoc access
- TrustRadius: Teladoc reviews hub
#3Amwell8.2/10
Verdict: Built for integrated delivery networks coordinating inpatient consults, nursing extensions, and branded digital front doors.
Pros
- Case studies such as Intermountain’s enterprise rollout translate hybrid care strategies into operational metrics executives recognize.
- Dr. Horner’s Medium interview surfaces bedside communication discipline buyers can test during pilots.
- Consumer familiarity grows when flagship systems advertise branded virtual programs on channels such as Ochsner’s Facebook updates.
Cons
- Deployment cadence reflects enterprise procurement rather than weekend go-lives common with lighter vendors.
- Crowded TrustRadius competitor grids mean differentiation hinges on workflow proofs, not logos alone per Amwell AW8 mappings.
Best for: Multi-hospital systems funding innovation offices that pair telemetry rooms with ambulatory expansion.
Evidence: Deep integration storytelling from Amwell’s Intermountain publication demonstrates outcomes Amwell executives cite in board decks, while Dr. Horner’s Medium guidance gives clinical leads language to evaluate beside manner remotely.
Links
- Official site: amwell.com
- Hospital solutions: business.amwell.com
- Reddit: hospitalist configuring remote programs
- TrustRadius: Amwell AW8 competitor landscape
#4Doxy.me7.8/10
Verdict: Fastest credible path for independent clinicians who need browser-first visits without enterprise command centers.
Pros
- TrustRadius reviewers emphasize approachable onboarding on doxy.me’s profile, critical for panels lacking dedicated IT benches.
- G2 comparison grids illustrate where Doxy.me trades enterprise orchestration for lightweight telemedicine depth.
- Therapist communities documented friction around V2 releases on r/therapists, proving active user bases watch every deploy.
Cons
- Those same threads capture outage anxiety during UI transitions, so sandbox testing remains mandatory per Reddit feedback.
- Facility-wide telemetry scenarios often require companion vendors beyond core video.
Best for: Solo practices, behavioral groups, and rural clinics prioritizing speed-to-live visits.
Evidence: Structured scores on TrustRadius anchor qualitative praise in peer-review format, while candid Reddit narratives expose operational risks buyers must mitigate before enterprise pledges.
Links
- Official site: doxy.me
- Pricing: doxy.me pricing
- Reddit: therapists discussing Doxy.me V2 stability
- G2: Doxy.me versus Spruce comparison
#5eVisit7.4/10
Verdict: Enterprise-grade configurability for teams that want branded patient journeys without surrendering local clinician relationships.
Pros
- TrustRadius metadata still frames eVisit inside enterprise telemedicine comparisons despite thinner crowdsourced volume on the product profile.
- Macro funding articles such as TechCrunch’s Sprinter Health piece reinforce buyer appetite for hybrid staffing models adjacent to virtual visits.
- Regulatory journalism including WIRED on telehealth formulary pivots underscores why configurable compliance workflows matter for governance-heavy deployments.
Cons
- Sparse TrustRadius averages demand heavier reference diligence than household brands per TrustRadius.
- Narrower consumer recognition lengthens security questionnaires versus Teladoc Health.
Best for: Regional systems standardizing virtual clinics while retaining revenue-cycle ownership inside existing operations teams.
Evidence: Profile-level positioning on TrustRadius clarifies eVisit’s enterprise emphasis, while TechCrunch and WIRED supply external proof that hybrid telehealth budgets remain politically important despite reimbursement noise.
Links
- Official site: evisit.com
- Platform overview: virtual care platform
- Reddit: clinicians debating EMR stacks tied to virtual expansion
- TrustRadius: eVisit reviews hub
Side-by-side comparison
| Criterion | Doximity | Teladoc Health | Amwell | Doxy.me | eVisit |
|---|---|---|---|---|---|
| Privacy, security, and compliance clarity | Strong HIPAA narrative tied to verified clinicians | Mature payer-grade controls | Hospital-grade governance packs | Lightweight HIPAA framing | Policy-heavy enterprise tooling |
| Pricing and overall value | Excellent once workflows consolidate | Enterprise bundles with noisy GAAP optics | Premium services ROI cases | Accessible tiers | Negotiated enterprise contracts |
| Clinical workflow and usability | Dialer plus video habits dominate | Consumer navigation layers | Facility-centric orchestration | Minimalist UX | Operator dashboards |
| Integration breadth with records and scheduling | Deep chart and routing adjacency | Employer connectors | EHR-heavy inpatient assets | Partner-led integrations | Enterprise scheduling emphasis |
| Community sentiment (Reddit, reviews, social) | KLAS praise versus trainee debates | Mixed payer Reddit threads | Strong hospital references | Passionate SMB feedback | Sparse but serious references |
| Score | 9.2 | 8.7 | 8.2 | 7.8 | 7.4 |
Methodology
Sources ran January 2025 through May 2026 across Reddit, TrustRadius, G2, Medium, TechCrunch, CNBC, Wired, Meta-hosted hospital posts, X updates, vendor press sites, and earnings distributors. Each criterion scored zero to ten subjectively, then combined via Σ (criterion_score × weight) using published weights. Privacy and workflow criteria receive extra influence because adoption dies when clinicians refuse the stack or compliance artifacts lag visits. Conflicting claims defaulted to filings, regulator-linked journalism, and timestamped discussions rather than anonymous anecdotes.
FAQ
Is Doximity only valuable if clinicians already socialize there?
No, yet ROI climbs fastest when specialists already trust the dialer and messaging rails, because telehealth modules inherit that behavior instead of fighting it.
Why rank Teladoc Health ahead of Amwell despite persistent GAAP losses?
Employers and payers still route enormous membership counts through Teladoc contracts, and public filings document where integrated-care segments offset softer lines. National buyers hunting one umbrella frequently meet Teladoc before niche vendors.
When does Amwell beat Doxy.me for mid-sized practices?
Pick Amwell when inpatient consults, nursing extensions, or multi-campus governance dominate roadmaps. Pick Doxy.me when you simply need credentialed outpatient video without enterprise war rooms.
How should teams read sparse TrustRadius metrics for eVisit?
Treat stars as directional. Demand specialty references, align pilots to throughput KPIs, and pair quantitative dashboards with security questionnaires tailored to your records environment.
Does GLP-1 telehealth enforcement affect platform choice?
Yes indirectly. Reporting such as WIRED’s telehealth pivot piece shows why prescription-policy tooling and audit trails inside any shortlisted vendor deserve scrutiny regardless of clinical specialty.
Sources
- Choosing Between EMRs — r/FamilyMedicine
- Policy says no telehealth benefits — r/HealthInsurance
- Telemedicine obesity setup — r/hospitalist
- Doxy.me V2 stability — r/therapists
- Don’t get misinformed — r/premed
Review and analyst surfaces
- doxy.me reviews — TrustRadius
- Teladoc reviews — TrustRadius
- Amwell AW8 competitors — TrustRadius
- eVisit reviews — TrustRadius
- Doxy.me versus Spruce — G2
- Doximity Talent Finder pricing — TrustRadius
Official press and filings
- KLAS recognition — Doximity press
- Teladoc FY 2025 results — GlobeNewswire
- Catapult Health acquisition — Teladoc Health newsroom
News
- Doximity fiscal Q3 earnings — CNBC
- Doximity share reaction — CNBC
- Teladoc Q4 2025 earnings — CNBC
- Telehealth GLP-1 pivot — WIRED
- Sprinter Health funding — TechCrunch
Blogs and social
- Amwell physician interview — Medium Authority Magazine
- Ochsner virtual visits — Facebook
- Teladoc Health updates — X